BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001;21:437-451. [PMID: 11586471 DOI: 10.1055/s-2001-17558] [Cited by in Crossref: 354] [Cited by in F6Publishing: 340] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, Sato N. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol. 2007;46:286-294. [PMID: 17166617 DOI: 10.1016/j.jhep.2006.08.023] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 4.9] [Reference Citation Analysis]
2 Hu PF, Xie WF. Targeted RNA interference for hepatic fibrosis. Expert Opin Biol Ther. 2009;9:1305-1312. [PMID: 19723017 DOI: 10.1517/14712590903213677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Sancho-Bru P, Juez E, Moreno M, Khurdayan V, Morales-Ruiz M, Colmenero J, Arroyo V, Brenner DA, Ginès P, Bataller R. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells. Liver Int. 2010;30:31-41. [PMID: 19929904 DOI: 10.1111/j.1478-3231.2009.02161.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
4 Coppola N, Perna A, Lucariello A, Martini S, Macera M, Carleo MA, Guerra G, Esposito V, De Luca A. Effects of treatment with Maraviroc a CCR5 inhibitor on a human hepatic stellate cell line. J Cell Physiol 2018;233:6224-31. [PMID: 29336497 DOI: 10.1002/jcp.26485] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
5 Namsen R, Rojanasthien N, Sireeratawong S, Rojsanga P, Nimlamool W, Potikanond S. Thunbergia laurifolia Exhibits Antifibrotic Effects in Human Hepatic Stellate Cells. Evid Based Complement Alternat Med 2017;2017:3508569. [PMID: 29410686 DOI: 10.1155/2017/3508569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Paulo JA, Kadiyala V, Banks PA, Conwell DL, Steen H. Mass spectrometry-based quantitative proteomic profiling of human pancreatic and hepatic stellate cell lines. Genomics Proteomics Bioinformatics. 2013;11:105-113. [PMID: 23528454 DOI: 10.1016/j.gpb.2013.01.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kumar A, Blackshear C, Subauste JS, Esfandiari NH, Oral EA, Subauste AR. Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study. J Endocr Soc 2017;1:460-9. [PMID: 29264501 DOI: 10.1210/js.2017-00055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Taleb H, Maddocks SE, Morris RK, Kanekanian AD. Chemical characterisation and the anti-inflammatory, anti-angiogenic and antibacterial properties of date fruit (Phoenix dactylifera L.). Journal of Ethnopharmacology 2016;194:457-68. [DOI: 10.1016/j.jep.2016.10.032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
9 Orr JG, Leel V, Cameron GA, Marek CJ, Haughton EL, Elrick LJ, Trim JE, Hawksworth GM, Halestrap AP, Wright MC. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 2004;40:232-242. [PMID: 15239107 DOI: 10.1002/hep.20254] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
10 Liu Y, Shimizu I, Omoya T, Ito S, Gu XS, Zuo J. Protective effect of estradiol on hepatocytic oxidative damage. World J Gastroenterol 2002; 8(2): 363-366 [PMID: 11925626 DOI: 10.3748/wjg.v8.i2.363] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
11 Siegmund SV, Dooley S, Brenner DA. Molecular Mechanisms of Alcohol-Induced Hepatic Fibrosis. Dig Dis 2006;23:264-74. [DOI: 10.1159/000090174] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
12 Dranoff JA, Ogawa M, Kruglov EA, Gaça MD, Sévigny J, Robson SC, Wells RG. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2004;287:G417-G424. [PMID: 14764443 DOI: 10.1152/ajpgi.00294.2003] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
13 Ma JC, Huang X, Shen YW, Zheng C, Su QH, Xu JK, Zhao J. Tenascin-C promotes migration of hepatic stellate cells and production of type I collagen. Biosci Biotechnol Biochem 2016;80:1470-7. [PMID: 27031437 DOI: 10.1080/09168451.2016.1165600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
14 Ayonrinde OT, Olynyk JK. PAHA model: an alternative non-invasive predictor of liver cirrhosis in patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2010;25:3-4. [PMID: 20136968 DOI: 10.1111/j.1440-1746.2009.06041.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Zhou L, Dong X, Wang L, Shan L, Li T, Xu W, Ding Y, Lai M, Lin X, Dai M, Bai X, Jia C, Zheng H. Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway. Oncotarget 2017;8:56267-80. [PMID: 28915589 DOI: 10.18632/oncotarget.17453] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
16 Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, Kawada N. Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair. 2012;5:12. [PMID: 22849305 DOI: 10.1186/1755-1536-5-12] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 6.4] [Reference Citation Analysis]
17 Yang G, Zhan J, Yang Y, Yuan L, Wang P, Ho C, Li S. Inhibitory effects of oxyresveratrol on ERK and Smad1/2 phosphorylation and HSC activation in preventing carbon tetrachloride-induced rat liver fibrosis. Food Science and Human Wellness 2021;10:6-12. [DOI: 10.1016/j.fshw.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Liu X, Zhao X. Scoparone attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway. Biomedicine & Pharmacotherapy 2017;93:57-61. [DOI: 10.1016/j.biopha.2017.06.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
19 Shteyer E, Ramm GA, Xu C, White FV, Shepherd RW. Outcome after portoenterostomy in biliary atresia: pivotal role of degree of liver fibrosis and intensity of stellate cell activation. J Pediatr Gastroenterol Nutr. 2006;42:93-99. [PMID: 16385261 DOI: 10.1097/01.mpg.0000189324.80323.a6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
20 Chen L, Guo YZ, Li AD, Ma JJ, Hao HY, Zhang D, Wang Y, Ji CG, Qi W, Wang J, Jiang HQ. Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells. Dig Dis Sci 2016;61:1961-71. [PMID: 26879903 DOI: 10.1007/s10620-016-4075-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 De Minicis S, Brenner DA. NOX in liver fibrosis. Arch Biochem Biophys. 2007;462:266-272. [PMID: 17531188 DOI: 10.1016/j.abb.2007.04.016] [Cited by in Crossref: 112] [Cited by in F6Publishing: 110] [Article Influence: 8.0] [Reference Citation Analysis]
22 Magness ST, Bataller R, Yang L, Brenner DA. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology. 2004;40:1151-1159. [PMID: 15389867 DOI: 10.1002/hep.20427] [Cited by in Crossref: 176] [Cited by in F6Publishing: 179] [Article Influence: 10.4] [Reference Citation Analysis]
23 Reif S, Aeed H, Shilo Y, Reich R, Kloog Y, Kweon YO, Bruck R. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid. J Hepatol. 2004;41:235-241. [PMID: 15288472 DOI: 10.1016/j.jhep.2004.04.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
24 De Minicis S, Bataller R, Brenner DA. NADPH oxidase in the liver: defensive, offensive, or fibrogenic? Gastroenterology. 2006;131:272-275. [PMID: 16831609 DOI: 10.1053/j.gastro.2006.05.048] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 5.9] [Reference Citation Analysis]
25 Sekiya Y, Ogawa T, Iizuka M, Yoshizato K, Ikeda K, Kawada N. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol. 2011;226:2535-2542. [PMID: 21792910 DOI: 10.1002/jcp.22598] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 5.8] [Reference Citation Analysis]
26 Lim Y, Lee HC, Lee H. Switch of cadherin expression from E- to N-type during the activation of rat hepatic stellate cells. Histochem Cell Biol 2007;127:149-60. [DOI: 10.1007/s00418-006-0233-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
27 Ohyama T, Sato K, Kishimoto K, Yamazaki Y, Horiguchi N, Ichikawa T, Kakizaki S, Takagi H, Izumi T, Mori M. Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence. Br J Pharmacol. 2012;165:1173-1187. [PMID: 21790536 DOI: 10.1111/j.1476-5381.2011.01599.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
28 Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW, Yun YH, Jung Y. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 2016;7:10993. [PMID: 27001906 DOI: 10.1038/ncomms10993] [Cited by in Crossref: 120] [Cited by in F6Publishing: 120] [Article Influence: 24.0] [Reference Citation Analysis]
29 Matsui H, Kawada N. Effect of S-adenosyl-L-methionine on the activation, proliferation and contraction of hepatic stellate cells. Eur J Pharmacol. 2005;509:31-36. [PMID: 15713426 DOI: 10.1016/j.ejphar.2004.12.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
30 Arabpour M, Poelstra K, Helfrich W, Bremer E, Haisma HJ. Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL). J Gene Med. 2014;16:281-290. [PMID: 25088657 DOI: 10.1002/jgm.2776] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
31 Zou YH, Yang Y, Li J, Wu Q, Li WP, Lu JT, Roberts MS. Potential therapeutic effects of a traditional Chinese formulation, BJ-JN, on liver fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol. 2008;120:452-457. [PMID: 18951966 DOI: 10.1016/j.jep.2008.09.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
32 Amoras Eda S, Gomes ST, Freitas FB, Santana BB, Ishak G, de Araújo MT, Demachki S, da Silva Conde SR, de Oliveira Guimarães Ishak M, Ishak R, Vallinoto AC. NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes. PLoS One 2015;10:e0121754. [PMID: 25816145 DOI: 10.1371/journal.pone.0121754] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
33 Vickers AE, Fisher R, Olinga P, Dial S. Repair pathways evident in human liver organ slices. Toxicology in Vitro 2011;25:1485-92. [DOI: 10.1016/j.tiv.2011.04.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
34 Wang LS, Chen YW, Li DG, Lu HM. Arg-gly-asp-mannose-6-phosphate inhibits activation and proliferation of hepatic stellate cells in vitro. World J Gastroenterol 2006; 12(8): 1303-1307 [PMID: 16534891 DOI: 10.3748/wjg.v12.i8.1303] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
35 Wang XZ, Zhang SJ, Chen YX, Chen ZX, Huang YH, Zhang LJ. Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitroWorld J Gastroenterol 2004; 10(18): 2706-2710 [PMID: 15309723 DOI: 10.3748/wjg.v10.i18.2706] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
36 Yang JA, Kong WH, Sung DK, Kim H, Kim TH, Lee KC, Hahn SK. Hyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis. Acta Biomater 2015;12:174-82. [PMID: 25305513 DOI: 10.1016/j.actbio.2014.10.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
37 Bexfield N. Canine Idiopathic Chronic Hepatitis. Vet Clin North Am Small Anim Pract 2017;47:645-63. [PMID: 28063746 DOI: 10.1016/j.cvsm.2016.11.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
38 Wang Y, Zhang JS, Huang GC, Cheng Q, Zhao ZH. Effects of adrenomedullin gene overexpression on biological behavior of hepatic stellate cells. World J Gastroenterol 2005; 11(23): 3549-3553 [PMID: 15962372 DOI: 10.3748/wjg.v11.i23.3549] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
39 Bedossa P, Paradis V. Approaches for treatment of liver fibrosis in chronic hepatitis C. Clin Liver Dis. 2003;7:195-210. [PMID: 12691467 DOI: 10.1016/s1089-3261(02)00076-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
40 Traber PG, Zomer E. Therapy of experimental NASH and fibrosis with galectin inhibitors. PLoS One. 2013;8:e83481. [PMID: 24367597 DOI: 10.1371/journal.pone.0083481] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 13.9] [Reference Citation Analysis]
41 Hui AY, Liew CT, Go MY, Chim AM, Chan HL, Leung NW, Sung JJ. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B. Liver Int. 2004;24:611-618. [PMID: 15566512 DOI: 10.1111/j.1478-3231.2004.0957.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
42 Rao HY, Wei L, Wang JH, Fei R, Jiang D, Zhang Q, Chen HS, Cong X. Inhibitory effect of human interferon-beta-1a on activated rat and human hepatic stellate cells. J Gastroenterol Hepatol. 2010;25:1777-1784. [PMID: 21039841 DOI: 10.1111/j.1440-1746.2010.06264.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
43 Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38-S53. [PMID: 12591185 DOI: 10.1016/s0168-8278(02)00429-4] [Cited by in Crossref: 1077] [Cited by in F6Publishing: 451] [Article Influence: 59.8] [Reference Citation Analysis]
44 Zhang K, Zhang YQ, Ai WB, Hu QT, Zhang QJ, Wan LY, Wang XL, Liu CB, Wu JF. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling. World J Gastroenterol 2015; 21(3): 878-887 [PMID: 25624721 DOI: 10.3748/wjg.v21.i3.878] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
45 Hui Y, Wang X, Yu Z, Fan X, Cui B, Zhao T, Mao L, Feng H, Lin L, Yu Q, Zhang J, Wang B, Chen X, Zhao X, Sun C. Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action. Pharmacological Research 2020;160:105170. [DOI: 10.1016/j.phrs.2020.105170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Mußbach F, Ungefroren H, Günther B, Katenkamp K, Henklein P, Westermann M, Settmacher U, Lenk L, Sebens S, Müller JP, Böhmer FD, Kaufmann R. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo. Mol Cancer 2016;15:54. [PMID: 27473374 DOI: 10.1186/s12943-016-0538-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
47 Gross JB. Nonresponders to Previous Chronic Hepatitis C Treatment. Curr Treat Options Gastroenterol 2004;7:469-75. [PMID: 15527713 DOI: 10.1007/s11938-004-0006-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Branski RC, Verdolini K, Sandulache V, Rosen CA, Hebda PA. Vocal Fold Wound Healing: A Review for Clinicians. Journal of Voice 2006;20:432-42. [DOI: 10.1016/j.jvoice.2005.08.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
49 Imanishi Y, Maeda N, Otogawa K, Seki S, Matsui H, Kawada N, Arakawa T. Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J Hepatol 2004;41:242-50. [PMID: 15288473 DOI: 10.1016/j.jhep.2004.04.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
50 Tseng TH, Lin WL, Chen ZH, Lee YJ, Shie MS, Lee KF, Shen CH, Kuo HC. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo. J Transl Med 2016;14:263. [PMID: 27612633 DOI: 10.1186/s12967-016-1022-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
51 Wang Y, Zhang X, Yang Y, Yang X, Ye B. Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo. Mar Drugs 2015;13:5201-18. [PMID: 26295240 DOI: 10.3390/md13085201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Hu KQ. Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases. Prostaglandins Leukot Essent Fatty Acids 2003;69:329-37. [PMID: 14580367 DOI: 10.1016/j.plefa.2003.07.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
53 Hirano S, Bless D, Heisey D, Ford C. Roles of Hepatocyte Growth Factor and Transforming Growth Factor ??1 in Production of Extracellular Matrix by Canine Vocal Fold Fibroblasts: . The Laryngoscope 2003;113:144-8. [DOI: 10.1097/00005537-200301000-00027] [Cited by in Crossref: 81] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
54 Forns X, Sánchez Tapias JM, Parés A, Llovet JM, Bruix J, Rodés J. Expected developments in hepatology. Best Practice & Research Clinical Gastroenterology 2002;16:957-70. [DOI: 10.1053/bega.2002.0341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
55 Rimola A, Londoño MC, Guevara G, Bruguera M, Navasa M, Forns X, García-Retortillo M, García-Valdecasas JC, Rodes J. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation. Transplantation 2004;78:686-91. [PMID: 15371669 DOI: 10.1097/01.tp.0000128913.09774.ce] [Cited by in Crossref: 73] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
56 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1111/J.1528-4934.2006.th00292.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Zhu D, Wang J, Sun X, Chen J, Duan Y, Pan J, Xu T, Qin Y, He X, Huang C. Septin4_i1 regulates apoptosis in hepatic stellate cells through peroxisome proliferator-activated receptor-γ/Akt/B-cell lymphoma 2 pathway. J Histochem Cytochem 2015;63:163-9. [PMID: 25527525 DOI: 10.1369/0022155414567230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
58 Friedman SL, Bansal MB. Reversal of hepatic fibrosis — Fact or fantasy? Hepatology 2006;43:S82-8. [DOI: 10.1002/hep.20974] [Cited by in Crossref: 267] [Cited by in F6Publishing: 262] [Article Influence: 17.8] [Reference Citation Analysis]
59 Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, Fernandez-Barrena MG. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells 2020;9:E2321. [PMID: 33086678 DOI: 10.3390/cells9102321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
60 Chen C, Li H, Xie Q, Shang H, Ji J, Bai S, Cao Y, Ma Y, Bi Y. Transcriptional profiling of host gene expression in chicken liver tissues infected with oncogenic Marek's disease virus. J Gen Virol 2011;92:2724-33. [PMID: 21832007 DOI: 10.1099/vir.0.034066-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
61 Osawa Y, Kojika E, Hayashi Y, Kimura M, Nishikawa K, Yoshio S, Doi H, Kanto T, Kimura K. Tumor necrosis factor-α-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice. Hepatol Commun 2018;2:407-20. [PMID: 29619419 DOI: 10.1002/hep4.1158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
62 Abbas G, Silveira MG, Lindor KD. Hepatic fibrosis and the renin-angiotensin system. Am J Ther 2011;18:e202-8. [PMID: 20535005 DOI: 10.1097/MJT.0b013e3181df8df5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
63 Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res. 2008;25:249-258. [PMID: 17577645 DOI: 10.1007/s11095-007-9311-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
64 Abe H, Kamimura K, Kobayashi Y, Ohtsuka M, Miura H, Ohashi R, Yokoo T, Kanefuji T, Suda T, Tsuchida M. Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis Model. Mol Ther Nucleic Acids. 2016;5:e276. [PMID: 26730813 DOI: 10.1038/mtna.2015.49] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
65 Yang L, Zhang CZ, Zhu QJ. Kangxian ruangan keli inhibits hepatic stellate cell proliferation mediated by PDGF. World J Gastroenterol 2003; 9(9): 2050-2053 [PMID: 12970904 DOI: 10.3748/wjg.v9.i9.2050] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
66 Luk JM, Zhang Q, Lee NP, Wo JY, Leung PP, Liu L, Hu M, Cheung K, Hui C, Lau GK, Fan S. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. Liver Int 2007;27:548-57. [DOI: 10.1111/j.1478-3231.2007.01452.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
67 Han J, Liang H, Yi J, Tan W, He S, Wang S, Li F, Wu X, Ma J, Shi X, Guo X, Bai C. Long-Term Selenium-Deficient Diet Induces Liver Damage by Altering Hepatocyte Ultrastructure and MMP1/3 and TIMP1/3 Expression in Growing Rats. Biol Trace Elem Res 2017;175:396-404. [PMID: 27339256 DOI: 10.1007/s12011-016-0781-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
68 Shay JES, Hamilton JP. Hepatic fibrosis: Avenues of investigation and clinical implications. Clin Liver Dis (Hoboken) 2018;11:111-4. [PMID: 30992799 DOI: 10.1002/cld.702] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
69 Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV. Systematic review: hepatic fibrosis - regression with therapy. Aliment Pharmacol Ther 2008;28:1175-87. [PMID: 18761707 DOI: 10.1111/j.1365-2036.2008.03840.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
70 Davis GL, Krawczynski K, Szabo G. Hepatitis C Virus Infection—Pathobiology and Implications for New Therapeutic Options. Dig Dis Sci 2007;52:857-75. [DOI: 10.1007/s10620-006-9484-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
71 徐静, 陈光. 骨髓间充质干细胞逆转肝纤维化的研究进展. 世界华人消化杂志 2010; 18(22): 2291-2295 [DOI: 10.11569/wcjd.v18.i22.2291] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
72 Yu C, Wang F, Jin C, Huang X, Miller DL, Basilico C, McKeehan WL. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol. 2003;163:1653-1662. [PMID: 14507672 DOI: 10.1016/s0002-9440(10)63522-5] [Cited by in Crossref: 118] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
73 Wimborne HJ, Takemoto K, Woster PM, Rockey DC, Lemasters JJ, Zhong Z. Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice. Free Radic Biol Med 2019;145:136-45. [PMID: 31557514 DOI: 10.1016/j.freeradbiomed.2019.09.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Marek CJ, Tucker SJ, Konstantinou DK, Elrick LJ, Haefner D, Sigalas C, Murray GI, Goodwin B, Wright MC. Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J 2005;387:601-8. [PMID: 15595924 DOI: 10.1042/BJ20041598] [Cited by in Crossref: 70] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
75 Elshazly SM, Mahmoud AAA. Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats. Naunyn-Schmiedeberg's Arch Pharmacol 2014;387:559-67. [DOI: 10.1007/s00210-014-0968-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
76 Schachtrup C, Le Moan N, Passino MA, Akassoglou K. Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair. Cell Cycle. 2011;10:1764-1771. [PMID: 21555919 DOI: 10.4161/cc.10.11.15828] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
77 Wang Z, Wang J, Hu C, Cao W, Shen X, Wu M, Shen L, Wu S. The effect of down-regulation of Smad3 by RNAi on hepatic stellate cells and a carbon tetrachloride-induced rat model of hepatic fibrosis. Braz J Med Biol Res 2011;44:91-9. [DOI: 10.1590/s0100-879x2010007500132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
78 Kim SM, Choi JE, Hur W, Kim JH, Hong SW, Lee EB, Lee JH, Li TZ, Sung PS, Yoon SK. RAR-Related Orphan Receptor Gamma (ROR-γ) Mediates Epithelial-Mesenchymal Transition Of Hepatocytes During Hepatic Fibrosis. J Cell Biochem 2017;118:2026-36. [PMID: 27791279 DOI: 10.1002/jcb.25776] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
79 Hirano S, Bless DM, Hartig GK, Massey RJ, Ford CN. Morphological and Functional Changes of Human Vocal Fold Fibroblasts with Hepatocyte Growth Factor. Ann Otol Rhinol Laryngol 2016;112:1026-33. [DOI: 10.1177/000348940311201206] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
80 Nagler A, Ohana M, Shibolet O, Shapira M, Alper R, Vlodavsky I, Pines M, Ilan Y. Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. European Journal of Cancer 2004;40:1397-403. [DOI: 10.1016/j.ejca.2003.11.036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
81 Sasaki Y, Dehnad A, Fish S, Sato A, Jiang J, Tian J, Schröder K, Brandes R, Török NJ. NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease. Sci Rep 2017;7:46144. [PMID: 28383062 DOI: 10.1038/srep46144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
82 Sancho-bru P, Bataller R, Colmenero J, Gasull X, Moreno M, Arroyo V, Brenner DA, Ginès P. Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006;291:G877-84. [DOI: 10.1152/ajpgi.00537.2005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
83 Bartalis J, Halaweish FT. In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines. Bioorganic & Medicinal Chemistry 2011;19:2757-66. [DOI: 10.1016/j.bmc.2011.01.037] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
84 Liu C, Sun M, Wang L, Wang G, Chen G, Liu C, Liu P. Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats. Chin Med. 2008;3:1. [PMID: 18237412 DOI: 10.1186/1749-8546-3-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
85 Liu XJ, Yang L, Mao YQ, Wang Q, Huang MH, Wang YP, Wu HB. Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells. World J Gastroenterol 2002; 8(4): 739-745 [PMID: 12174389 DOI: 10.3748/wjg.v8.i4.739] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
86 Lang Q, Liu Q, Xu N, Qian KL, Qi JH, Sun YC, Xiao L, Shi XF. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Biochem Biophys Res Commun. 2011;409:448-453. [PMID: 21600192 DOI: 10.1016/j.bbrc.2011.05.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
87 Wang Z, Deng C, Zheng H, Xie C, Wang X, Luo Y, Chen Z, Cheng P, Chen L. (Z)2-(5-(4-methoxybenzylidene)-2, 4-dioxothiazolidin-3-yl) acetic acid protects rats from CCl4-induced liver injury: MDA protects rats from CCl4-hepatitis. Journal of Gastroenterology and Hepatology 2012;27:966-73. [DOI: 10.1111/j.1440-1746.2011.06913.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
88 Martínez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53:325-335. [PMID: 21254180 DOI: 10.1002/hep.24013] [Cited by in Crossref: 272] [Cited by in F6Publishing: 248] [Article Influence: 24.7] [Reference Citation Analysis]
89 Elrick LJ, Leel V, Blaylock MG, Duncan L, Drever MR, Strachan G, Charlton KA, Koruth M, Porter AJ, Wright MC. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics. J Hepatol. 2005;42:888-896. [PMID: 15885360 DOI: 10.1016/j.jhep.2005.01.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
90 Durham AE, Smith KC, Newton JR, Hillyer MH, Hillyer LL, Smith MRW, Marr CM. Development and application of a scoring system for prognostic evaluation of equine liver biopsies. Equine Veterinary Journal 2003;35:534-40. [DOI: 10.2746/042516403775467171] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
91 Lee JS, Kang Decker N, Chatterjee S, Yao J, Friedman S, Shah V. Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol. 2005;166:1861-1870. [PMID: 15920170 DOI: 10.1016/S0002-9440(10)62495-9] [Cited by in Crossref: 67] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
92 Chen Y, Zhao C, Liu X, Wu G, Zhong J, Zhao T, Li J, Lin Y, Zhou Y, Wei Y. Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-кB signaling pathway in vitro and in vivo. Biomed Pharmacother 2019;116:108923. [PMID: 31154269 DOI: 10.1016/j.biopha.2019.108923] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
93 Wang H, Zhang Y, Heuckeroth RO. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA. FEBS Lett. 2007;581:3098-3104. [PMID: 17561000 DOI: 10.1016/j.febslet.2007.05.049] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
94 Mohamed YS, Ahmed LA, Salem HA, Agha AM. Role of nitric oxide and KATP channel in the protective effect mediated by nicorandil in bile duct ligation-induced liver fibrosis in rats. Biochemical Pharmacology 2018;151:135-42. [DOI: 10.1016/j.bcp.2018.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
95 Ghazwani M, Zhang Y, Gao X, Fan J, Li J, Li S. Anti-fibrotic effect of thymoquinone on hepatic stellate cells. Phytomedicine. 2014;21:254-260. [PMID: 24182989 DOI: 10.1016/j.phymed.2013.09.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
96 Yang C, Lee M, Hsu S, Chang CJ. Supercritical fluids extraction of capillarisin from Artemisia capillaris and its inhibition of in vitro growth of hepatoma cells. The Journal of Supercritical Fluids 2007;42:96-103. [DOI: 10.1016/j.supflu.2006.12.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
97 Otogawa K, Ogawa T, Shiga R, Ikeda K, Kawada N. Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis. Hepatol Int 2009;3:378-83. [PMID: 19669364 DOI: 10.1007/s12072-008-9113-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
98 Park JH, Jo JH, Kim KH, Kim SJ, Lee WR, Park KK, Park JB. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis. J Gene Med. 2009;11:824-833. [PMID: 19554625 DOI: 10.1002/jgm.1355] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
99 Saugspier M, Dorn C, Thasler WE, Gehrig M, Heilmann J, Hellerbrand C. Hop bitter acids exhibit anti-fibrogenic effects on hepatic stellate cells in vitro. Experimental and Molecular Pathology 2012;92:222-8. [DOI: 10.1016/j.yexmp.2011.11.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
100 Watson P. Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. The Veterinary Journal 2004;167:228-41. [DOI: 10.1016/s1090-0233(03)00118-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
101 Liu XJ, Yang L, Mao YQ, Wang Q, Huang MH, Wang YP, Wu HB. Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells. World J Gastroenterol. 2002;8:739-745. [PMID: 12174389 DOI: 10.3748/wjg.v8.i4.739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Haywood S, Müller T, Mackenzie AM, Müller W, Tanner MS, Heinz-Erian P, Williams CL, Loughran MJ. Copper-induced hepatotoxicosis with hepatic stellate cell activation and severe fibrosis in North Ronaldsay lambs: a model for non-Wilsonian hepatic copper toxicosis of infants. J Comp Pathol 2004;130:266-77. [PMID: 15053929 DOI: 10.1016/j.jcpa.2003.11.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
103 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/jci200524282] [Cited by in Crossref: 211] [Cited by in F6Publishing: 15] [Article Influence: 13.2] [Reference Citation Analysis]
104 Ruehl M, Erben U, Kim K, Freise C, Dagdelen T, Eisele S, Trowitzsch-Kienast W, Zeitz M, Jia J, Stickel F. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern. J Nutr Biochem. 2009;20:597-606. [PMID: 18824344 DOI: 10.1016/j.jnutbio.2008.06.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
105 Hamadeh HK, Jayadev S, Gaillard ET, Huang Q, Stoll R, Blanchard K, Chou J, Tucker CJ, Collins J, Maronpot R, Bushel P, Afshari CA. Integration of clinical and gene expression endpoints to explore furan-mediated hepatotoxicity. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2004;549:169-83. [DOI: 10.1016/j.mrfmmm.2003.12.021] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
106 Yang N, Dang S, Shi J, Wu F, Li M, Zhang X, Li Y, Jia X, Zhai S. Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway. Biochem Biophys Res Commun 2017;486:22-8. [PMID: 28193525 DOI: 10.1016/j.bbrc.2017.02.057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
107 Thieringer F, Maass T, Czochra P, Klopcic B, Conrad I, Friebe D, Schirmacher P, Lohse AW, Blessing M, Galle PR, Teufel A, Kanzler S. Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. Gene. 2008;423:23-28. [PMID: 18598744 DOI: 10.1016/j.gene.2008.05.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
108 Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, Brenner DA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest. 2003;112:1383-1394. [PMID: 14597764 DOI: 10.1172/jci18212] [Cited by in Crossref: 384] [Cited by in F6Publishing: 173] [Article Influence: 21.3] [Reference Citation Analysis]
109 Husain H, Ahmad R, Khan A, Inamuddin, Asiri AM. Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis. International Journal of Biological Macromolecules 2018;111:379-92. [DOI: 10.1016/j.ijbiomac.2017.12.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
110 Zhang X, Han X, Yin L, Xu L, Qi Y, Xu Y, Sun H, Lin Y, Liu K, Peng J. Potent effects of dioscin against liver fibrosis. Sci Rep. 2015;5:9713. [PMID: 25853178 DOI: 10.1038/srep09713] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 10.5] [Reference Citation Analysis]
111 Kumstel S, Tang G, Zhang X, Kerndl H, Vollmar B, Zechner D. Grading Distress of Different Animal Models for Gastrointestinal Diseases Based on Plasma Corticosterone Kinetics. Animals (Basel) 2019;9:E145. [PMID: 30987232 DOI: 10.3390/ani9040145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
112 Osawa Y, Hoshi M, Yasuda I, Saibara T, Moriwaki H, Kozawa O. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PLoS One 2013;8:e65251. [PMID: 23755201 DOI: 10.1371/journal.pone.0065251] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
113 Cheng CF, Pan TM. Ankaflavin and Monascin Induce Apoptosis in Activated Hepatic Stellate Cells through Suppression of the Akt/NF-κB/p38 Signaling Pathway. J Agric Food Chem 2016;64:9326-34. [PMID: 27960292 DOI: 10.1021/acs.jafc.6b03700] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
114 Taimr P. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003;37:87-95. [DOI: 10.1053/jhep.2003.50002] [Cited by in Crossref: 155] [Cited by in F6Publishing: 155] [Article Influence: 8.6] [Reference Citation Analysis]
115 Irwin RD, Boorman GA, Cunningham ML, Heinloth AN, Malarkey DE, Paules RS. Application of Toxicogenomics to Toxicology: Basic Concepts in the Analysis of Microarray Data. Toxicol Pathol 2004;32:72-83. [DOI: 10.1080/01926230490424752] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
116 Jiang Y, Wang C, Li YY, Wang XC, An JD, Wang YJ, Wang XJ. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference. J Ethnopharmacol 2014;158 Pt A:230-8. [PMID: 25456431 DOI: 10.1016/j.jep.2014.10.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
117 MadanKumar P, NaveenKumar P, Manikandan S, Devaraj H, NiranjaliDevaraj S. Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling. Toxicol Appl Pharmacol 2014;277:210-20. [PMID: 24657339 DOI: 10.1016/j.taap.2014.03.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
118 Al-Rasheed NM, Attia HA, Mohamad RA, Al-Rasheed NM, Al-Amin MA, Al-Onazi A. Aqueous Date Flesh or Pits Extract Attenuates Liver Fibrosis via Suppression of Hepatic Stellate Cell Activation and Reduction of Inflammatory Cytokines, Transforming Growth Factor- β 1 and Angiogenic Markers in Carbon Tetrachloride-Intoxicated Rats. Evid Based Complement Alternat Med 2015;2015:247357. [PMID: 25945106 DOI: 10.1155/2015/247357] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
119 Parenteau NL, Rosenberg L, Hardin-Young J. The engineering of tissues using progenitor cells. Curr Top Dev Biol. 2004;64:101-139. [PMID: 15563946 DOI: 10.1016/s0070-2153(04)64006-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
120 Sancho-Bru P, Bataller R, Gasull X, Colmenero J, Khurdayan V, Gual A, Nicolás JM, Arroyo V, Ginès P. Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. J Hepatol. 2005;43:272-282. [PMID: 15964095 DOI: 10.1016/j.jhep.2005.02.035] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
121 Sun KH, Chang Y, Reed NI, Sheppard D. α-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFβ activation or collagen production across multiple models of organ fibrosis. Am J Physiol Lung Cell Mol Physiol 2016;310:L824-36. [PMID: 26944089 DOI: 10.1152/ajplung.00350.2015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 15.8] [Reference Citation Analysis]
122 Wang X, Tang X, Gong X, Albanis E, Friedman SL, Mao Z. Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2. Gastroenterology. 2004;127:1174-1188. [PMID: 15480995 DOI: 10.1053/j.gastro.2004.07.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
123 Jang YO, Jun BG, Baik SK, Kim MY, Kwon SO. Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis. Clin Mol Hepatol. 2015;21:141-149. [PMID: 26157751 DOI: 10.3350/cmh.2015.21.2.141] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
124 Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Kang YJ. Herbogenomics: From Traditional Chinese Medicine to Novel Therapeutics. Exp Biol Med (Maywood) 2008;233:1059-65. [DOI: 10.3181/0802-mr-47] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
126 Song G, Yang R, Zhang Q, Chen L, Huang D, Zeng J, Yang C, Zhang T. TGF-β Secretion by M2 Macrophages Induces Glial Scar Formation by Activating Astrocytes In Vitro. J Mol Neurosci 2019;69:324-32. [PMID: 31327154 DOI: 10.1007/s12031-019-01361-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
127 Huang Y, Feng H, Kan T, Huang B, Zhang M, Li Y, Shi C, Wu M, Luo Y, Yang J, Xu F. Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells. PLoS One 2013;8:e73492. [PMID: 24023685 DOI: 10.1371/journal.pone.0073492] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
128 Son G, Iimuro Y, Seki E, Hirano T, Kaneda Y, Fujimoto J. Selective inactivation of NF-κB in the liver using NF-κB decoy suppresses CCl 4 -induced liver injury and fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007;293:G631-9. [DOI: 10.1152/ajpgi.00185.2007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 87] [Article Influence: 5.8] [Reference Citation Analysis]
129 Yang L, Jung Y, Omenetti A, Witek RP, Choi S, Vandongen HM, Huang J, Alpini GD, Diehl AM. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008;26:2104-13. [PMID: 18511600 DOI: 10.1634/stemcells.2008-0115] [Cited by in Crossref: 151] [Cited by in F6Publishing: 153] [Article Influence: 11.6] [Reference Citation Analysis]
130 Nitti M, Pronzato MA, Marinari UM, Domenicotti C. PKC signaling in oxidative hepatic damage. Mol Aspects Med. 2008;29:36-42. [PMID: 18035409 DOI: 10.1016/j.mam.2007.09.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
131 Maubach G, Lim MC, Zhuo L. Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells. Mol Biol Cell 2008;19:4238-48. [PMID: 18667530 DOI: 10.1091/mbc.e08-03-0291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
132 Huang Q, Li Y, Zhang S, Huang R, Zheng L, Wei L, He M, Liao M, Li L, Zhuo L, Lin X. Effect and mechanism of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) on hepatic fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol 2012;143:889-95. [PMID: 22967666 DOI: 10.1016/j.jep.2012.08.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
133 Patsenker E, Popov Y, Wiesner M, Goodman SL, Schuppan D. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J Hepatol 2007;46:878-87. [PMID: 17258347 DOI: 10.1016/j.jhep.2006.11.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
134 Hong JJ, Pan FY, Qian Y, Cheng LC, Zhang HX, Xue B, Li CJ. Overexpression of beta-catenin is responsible for the development of portal hypertension during liver cirrhosis. Anat Rec (Hoboken) 2009;292:818-26. [PMID: 19462446 DOI: 10.1002/ar.20897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
135 Longo-Santos LR, Teodoro WR, de Mello ES, Velosa AP, Parra ER, Capelozzi VL, Tannuri U. Early type I collagen deposition is associated with prognosis in biliary atresia. J Pediatr Surg 2016;51:379-85. [PMID: 26452701 DOI: 10.1016/j.jpedsurg.2015.08.061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
136 Zhang LJ, Chen YX, Chen ZX, Huang YH, Yu JP, Wang XZ. Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells. World J Gastroenterol 2004; 10(17): 2574-2579 [PMID: 15300910 DOI: 10.3748/wjg.v10.i17.2574] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
137 Myung SJ, Yoon JH, Gwak GY, Kim W, Yang JI, Lee SH, Jang JJ, Lee HS. Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation. Biochem Biophys Res Commun 2007;353:1091-6. [PMID: 17204245 DOI: 10.1016/j.bbrc.2006.12.157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
138 Kerola A, Lampela H, Lohi J, Heikkilä P, Mutanen A, Jalanko H, Pakarinen MP. Molecular signature of active fibrogenesis prevails in biliary atresia after successful portoenterostomy. Surgery 2017;162:548-56. [PMID: 28655415 DOI: 10.1016/j.surg.2017.04.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
139 Kim N, Choi S, Lim C, Lee H, Oh J. Albumin mediates PPAR-gamma or C/EBP-alpha-induced phenotypic changes in pancreatic stellate cells. Biochem Biophys Res Commun. 2010;391:640-644. [PMID: 19932685 DOI: 10.1016/j.bbrc.2009.11.112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
140 Tateya T, Tateya I, Surles RL, Tanumihardjo S, Bless DM. Roles of vitamin A and macula flava in maintaining vocal folds. Ann Otol Rhinol Laryngol 2008;117:65-73. [PMID: 18254374 DOI: 10.1177/000348940811700113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
141 Guo XH, Liu LX, Zhang HY, Zhang QQ, Li Y, Tian XX, Qiu ZH. Insulin-like growth factor binding protein-related protein 1 contributes to hepatic fibrogenesis. J Dig Dis. 2014;15:202-210. [PMID: 24373620 DOI: 10.1111/1751-2980.12126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
142 Mei S, Wang X, Zhang J, Qian J, Ji J. In vivo transfection of C/EBP-alpha gene could ameliorate CCL(4)-induced hepatic fibrosis in mice. Hepatol Res. 2007;37:531-539. [PMID: 17539996 DOI: 10.1111/j.1872-034x.2007.00074.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
143 Wang X, Ikejima K, Kon K, Arai K, Aoyama T, Okumura K, Abe W, Sato N, Watanabe S. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells. J Hepatol. 2011;55:379-387. [PMID: 21168456 DOI: 10.1016/j.jhep.2010.10.040] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
144 Gibelli NE, Tannuri U, Mello ES. Immunohistochemical studies of stellate cells in experimental cholestasis in newborn and adult rats. Clinics (Sao Paulo) 2008;63:689-94. [PMID: 18925331 DOI: 10.1590/s1807-59322008000500019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
145 Ma L, Liu J, Xiao E, Ning H, Li K, Shang J, Kang Y. MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells. Life Sci 2021;270:119144. [PMID: 33545201 DOI: 10.1016/j.lfs.2021.119144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
146 Habibie H, Adhyatmika A, Schaafsma D, Melgert BN. The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases. Pharmacol Ther 2021;228:107941. [PMID: 34171336 DOI: 10.1016/j.pharmthera.2021.107941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Yang L, Bataller R, Dulyx J, Coffman TM, Ginès P, Rippe RA, Brenner DA. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol. 2005;43:317-323. [PMID: 15964094 DOI: 10.1016/j.jhep.2005.02.034] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 5.5] [Reference Citation Analysis]
148 Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2010;391:316-321. [PMID: 19913496 DOI: 10.1016/j.bbrc.2009.11.056] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 7.8] [Reference Citation Analysis]
149 Kim J, Jung Y. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. Vitam Horm. 2016;102:121-149. [PMID: 27450733 DOI: 10.1016/bs.vh.2016.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
150 Wu LM, Wu XX, Sun Y, Kong XW, Zhang YH, Xu Q. A novel synthetic oleanolic acid derivative (CPU-II2) attenuates liver fibrosis in mice through regulating the function of hepatic stellate cells. J Biomed Sci. 2008;15:251-259. [PMID: 17922224 DOI: 10.1007/s11373-007-9216-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
151 Du X, Li H, Yang X, Li J, Xu J, Chen Y, Xu Q, Yang L, He C, Huang C, Meng X, Li J. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis. International Immunopharmacology 2019;75:105671. [DOI: 10.1016/j.intimp.2019.05.056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
152 Williams AS, Kang L, Wasserman DH. The extracellular matrix and insulin resistance. Trends Endocrinol Metab 2015;26:357-66. [PMID: 26059707 DOI: 10.1016/j.tem.2015.05.006] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 16.7] [Reference Citation Analysis]
153 Shafik AN, Khodeir MM, Gouda NA, Mahmoud ME. Improved antifibrotic effect of a combination of verapamil and silymarin in rat-induced liver fibrosis. Arab J Gastroenterol 2011;12:143-9. [PMID: 22055593 DOI: 10.1016/j.ajg.2011.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
154 Tang X, Yang J, Li J. Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis. Life Sciences 2009;84:552-7. [DOI: 10.1016/j.lfs.2009.01.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
155 He C, Miao X, Li J, Qi H. Angiotensin II induces endothelin-1 expression in human hepatic stellate cells. Dig Dis Sci. 2013;58:2542-2549. [PMID: 23625292 DOI: 10.1007/s10620-013-2685-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
156 Patsenker E, Stoll M, Millonig G, Agaimy A, Wissniowski T, Schneider V, Mueller S, Brenneisen R, Seitz HK, Ocker M. Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Mol Med. 2011;17:1285-1294. [PMID: 21863215 DOI: 10.2119/molmed.2011.00149] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
157 Wu JH, Wang YR, Huang WY, Tan RX. Anti-proliferative and pro-apoptotic effects of tectorigenin on hepatic stellate cells. World J Gastroenterol 2010; 16(31): 3911-3918 [PMID: 20712052 DOI: 10.3748/wjg.v16.i31.3911] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
158 Sevastianova K, Hakkarainen A, Kotronen A, Cornér A, Arkkila P, Arola J, Westerbacka J, Bergholm R, Lundbom J, Lundbom N, Yki-järvinen H. Nonalcoholic Fatty Liver Disease: Detection of Elevated Nicotinamide Adenine Dinucleotide Phosphate with in Vivo 3.0-T 31 P MR Spectroscopy with Proton Decoupling. Radiology 2010;256:466-73. [DOI: 10.1148/radiol.10091351] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
159 Li X, Shao S, Li H, Bi Z, Zhang S, Wei Y, Bai J, Zhang R, Ma X, Ma B, Zhang L, Xie C, Ning W, Zhou H, Yang C. Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice. J Cell Mol Med 2020;24:8623-35. [PMID: 32643868 DOI: 10.1111/jcmm.15493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Li J, Liu P, Zhang R, Cao L, Qian H, Liao J, Xu W, Wu M, Yin Z. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J Ethnopharmacol. 2011;137:714-723. [PMID: 21726622 DOI: 10.1016/j.jep.2011.06.030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
161 Russo MW, Firpi RJ, Nelson DR, Schoonhoven R, Shrestha R, Fried MW. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Liver Transpl. 2005;11:1235-1241. [PMID: 16184580 DOI: 10.1002/lt.20432] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
162 Lockwood D, Gotley D. Interaction of Tumour with Host Stroma in Hepatocellular Carcinoma. In: Meadows GG, editor. Integration/Interaction of Oncologic Growth. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 165-76. [DOI: 10.1007/1-4020-3414-8_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
163 Yoshida K, Matsuzaki K, Mori S, Tahashi Y, Yamagata H, Furukawa F, Seki T, Nishizawa M, Fujisawa J, Okazaki K. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol. 2005;166:1029-1039. [PMID: 15793284 DOI: 10.1016/s0002-9440(10)62324-3] [Cited by in Crossref: 120] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
164 Wang XM, Yu DM, McCaughan GW, Gorrell MD. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology. 2005;42:935-945. [PMID: 16175601 DOI: 10.1002/hep.20853] [Cited by in Crossref: 111] [Cited by in F6Publishing: 134] [Article Influence: 6.9] [Reference Citation Analysis]
165 Debernardi-Venon W, Martini S, Biasi F, Vizio B, Termine A, Poli G, Brunello F, Alessandria C, Bonardi R, Saracco G, Rizzetto M, Marzano A. AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. J Hepatol 2007;46:1026-33. [PMID: 17336417 DOI: 10.1016/j.jhep.2007.01.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
166 Liu XJ, Yang L, Wu HB, Qiang O, Huang MH, Wang YP. Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. World J Gastroenterol 2002; 8(4): 734-738 [PMID: 12174388 DOI: 10.3748/wjg.v8.i4.734] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
167 Zhou W, Inada M, Lee TP, Benten D, Lyubsky S, Bouhassira EE, Gupta S, Tsai HM. ADAMTS13 is expressed in hepatic stellate cells. Lab Invest 2005;85:780-8. [PMID: 15806136 DOI: 10.1038/labinvest.3700275] [Cited by in Crossref: 132] [Cited by in F6Publishing: 103] [Article Influence: 8.3] [Reference Citation Analysis]
168 Kikuchi H, Katsuramaki T, Kukita K, Taketani S, Meguro M, Nagayama M, Isobe M, Mizuguchi T, Hirata K. New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis. Wound Repair Regen. 2007;15:881-888. [PMID: 18028137 DOI: 10.1111/j.1524-475X.2007.00308.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
169 Wang J, Shin J, Son J, Cho J, Son C. Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats. Journal of Ethnopharmacology 2010;127:534-42. [DOI: 10.1016/j.jep.2009.10.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
170 Smirne C, Rigamonti C, De Benedittis C, Sainaghi PP, Bellan M, Burlone ME, Castello LM, Avanzi GC. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis. Dis Markers 2019;2019:2304931. [PMID: 31583026 DOI: 10.1155/2019/2304931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
171 Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology. 2004;126:529-540. [PMID: 14762790 DOI: 10.1053/j.gastro.2003.11.018] [Cited by in Crossref: 183] [Cited by in F6Publishing: 170] [Article Influence: 10.8] [Reference Citation Analysis]
172 Shi MN, Zheng WD, Zhang LJ, Chen ZX, Wang XZ. Effect of IL-10 on the expression of HSC growth factors in hepatic fibrosis rat. World J Gastroenterol 2005; 11(31): 4788-4793 [PMID: 16097045 DOI: 10.3748/wjg.v11.i31.4788] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
173 Reynaert H, Sermon F, Urbain D, Geerts A. Stellate cells in the digestive tract. Curr Gastroenterol Rep 2003;5:177-9. [DOI: 10.1007/s11894-003-0015-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
174 Raslan HM, Amr KS, Elhosary YA, Ezzat WM, Abdullah NA, El-Batae HE. Possible role of angiotensin-converting enzyme polymorphism on progression of hepatic fibrosis in chronic hepatitis C virus infection. Trans R Soc Trop Med Hyg. 2011;105:396-400. [PMID: 21546048 DOI: 10.1016/j.trstmh.2011.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
175 Albanis E, Safadi R, Friedman SL. Treatment of hepatic fibrosis: almost there. Curr Gastroenterol Rep. 2003;5:48-56. [PMID: 12530948 DOI: 10.1007/s11894-003-0009-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
176 Wu XX, Wu LM, Fan JJ, Qin Y, Chen G, Wu XF, Shen Y, Sun Y, Xu Q. Cortex Dictamni extract induces apoptosis of activated hepatic stellate cells via STAT1 and attenuates liver fibrosis in mice. J Ethnopharmacol. 2011;135:173-178. [PMID: 21396998 DOI: 10.1016/j.jep.2011.03.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
177 Reynaert H, Rombouts K, Jia Y, Urbain D, Chatterjee N, Uyama N, Geerts A. Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol. 2005;146:77-88. [PMID: 15980876 DOI: 10.1038/sj.bjp.0706298] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
178 Wang X, Niu C, Zhang X, Dong M. Emodin suppresses activation of hepatic stellate cells through p38 mitogen-activated protein kinase and Smad signaling pathways in vitro. Phytother Res 2018;32:2436-46. [PMID: 30117601 DOI: 10.1002/ptr.6182] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
179 Asai K, Tamakawa S, Yamamoto M, Yoshie M, Tokusashi Y, Yaginuma Y, Kasai S, Ogawa K. Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation. Liver Int. 2006;26:595-603. [PMID: 16762005 DOI: 10.1111/j.1478-3231.2006.01267.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
180 Brafman DA, de Minicis S, Seki E, Shah KD, Teng D, Brenner D, Willert K, Chien S. Investigating the role of the extracellular environment in modulating hepatic stellate cell biology with arrayed combinatorial microenvironments. Integr Biol (Camb) 2009;1:513-24. [PMID: 20023766 DOI: 10.1039/b912926j] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
181 韦燕飞, 钟振国, 黄仁彬, 彭岳, 谢海源, 段雪琳, 赵铁建. 白花丹醌对人肝星状细胞凋亡及相关蛋白表达的影响. 世界华人消化杂志 2011; 19(4): 349-354 [DOI: 10.11569/wcjd.v19.i4.349] [Reference Citation Analysis]
182 Ogawa T, Kawada N, Ikeda K. Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells. Hepatol Int 2009;3:497-503. [PMID: 19669254 DOI: 10.1007/s12072-009-9129-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
183 Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong P, Lu Z, Gao S, Liao Y, Chen B. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis. FEBS J. 2014;281:88-103. [PMID: 24138392 DOI: 10.1111/febs.12574] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
184 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/jci24282] [Cited by in Crossref: 3033] [Cited by in F6Publishing: 1550] [Article Influence: 189.6] [Reference Citation Analysis]
185 Schepke M, Wiest R, Flacke S, Heller J, Stoffel-Wagner B, Herold T, Ghauri M, Sauerbruch T. Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study. Am J Gastroenterol 2008;103:1152-8. [PMID: 18422814 DOI: 10.1111/j.1572-0241.2007.01759.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
186 Song YH, Chen XL, Kong XJ, Liu NZ, Li W, Wu XL, Lin JS, Jin YX. Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats. J Gene Med. 2005;7:965-976. [PMID: 15772939 DOI: 10.1002/jgm.744] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
187 Ikegami T, Zhang Y, Matsuzaki Y. Liver fibrosis: possible involvement of EMT. Cells Tissues Organs. 2007;185:213-221. [PMID: 17587827 DOI: 10.1159/000101322] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
188 Li J, Ghazwani M, Liu K, Huang Y, Chang N, Fan J, He F, Li L, Bu S, Xie W, Ma X, Li S. Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism. PLoS One 2017;12:e0182679. [PMID: 28797105 DOI: 10.1371/journal.pone.0182679] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
189 Tang W, Zhao Z, Chong Y, Wu C, Liu Q, Yang J, Zhou R, Lian Z, Liang G. Tandem Enzymatic Self-Assembly and Slow Release of Dexamethasone Enhances Its Antihepatic Fibrosis Effect. ACS Nano 2018;12:9966-73. [DOI: 10.1021/acsnano.8b04143] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
190 Chen CH, Kuo LM, Chang Y, Wu W, Goldbach C, Ross MA, Stolz DB, Chen L, Fung JJ, Lu L. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology. 2006;44:1171-1181. [PMID: 17058227 DOI: 10.1002/hep.21379] [Cited by in Crossref: 118] [Cited by in F6Publishing: 109] [Article Influence: 7.9] [Reference Citation Analysis]
191 Iredale JP. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ. 2003;327:143-147. [PMID: 12869458 DOI: 10.1136/bmj.327.7407.143;327/7407/143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
192 Wang Q, Dai X, Yang W, Wang H, Zhao H, Yang F, Yang Y, Li J, Lv X. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells. Int Immunopharmacol. 2015;25:340-352. [PMID: 25701503 DOI: 10.1016/j.intimp.2015.02.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
193 Park YJ, Lee KH, Jeon MS, Lee YH, Ko YJ, Pang C, Kim B, Chung KH, Kim KH. Hepatoprotective Potency of Chrysophanol 8-O-Glucoside from Rheum palmatum L. against Hepatic Fibrosis via Regulation of the STAT3 Signaling Pathway. Int J Mol Sci 2020;21:E9044. [PMID: 33261209 DOI: 10.3390/ijms21239044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Norton PA, Reis HM, Prince S, Larkin J, Pan J, Liu J, Gong Q, Zhu M, Feitelson MA. Activation of fibronectin gene expression by hepatitis B virus x antigen. J Viral Hepat 2004;11:332-41. [PMID: 15230856 DOI: 10.1111/j.1365-2893.2004.00555.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
195 Sbierski-Kind J, Mroz N, Molofsky AB. Perivascular stromal cells: Directors of tissue immune niches. Immunol Rev 2021;302:10-31. [PMID: 34075598 DOI: 10.1111/imr.12984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 周永莉, 段志军. 肝炎后肝硬化与酒精性肝硬化患者临床特征的比较及防治. 世界华人消化杂志 2010; 18(31): 3313-3319 [DOI: 10.11569/wcjd.v18.i31.3313] [Reference Citation Analysis]
197 Paredes BD, Faccioli LAP, Quintanilha LF, Asensi KD, Valle CZD, Canary PC, Takiya CM, Carvalho ACC, Goldenberg RCDS. Bone marrow progenitor cells do not contribute to liver fibrogenic cells. World J Hepatol 2012; 4(10): 274-283 [PMID: 23293712 DOI: 10.4254/wjh.v4.i10.274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
198 Huang Q, Wei J, Wei L, Zhang X, Bai F, Wen S, Wei Y, Tan S, Lu Z, Lin X. Retracted : Role of RKIP in human hepatic stellate cell proliferation, invasion, and metastasis. J Cell Biochem 2019;120:6168-77. [DOI: 10.1002/jcb.27904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
199 Patel G, Kher G, Misra A. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes. J Drug Target. 2012;20:155-165. [PMID: 21913877 DOI: 10.3109/1061186x.2011.610800] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
200 Hyun J, Jung Y. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling. World J Gastroenterol 2016; 22(29): 6652-6662 [PMID: 27547008 DOI: 10.3748/wjg.v22.i29.6652] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
201 Bi S, Chu F, Wang M, Li B, Mao P, Zhang H, Wang P, Guo W, Xu L, Ren L, Lei H, Zhang Y. Ligustrazine-Oleanolic Acid Glycine Derivative, G-TOA, Selectively Inhibited the Proliferation and Induced Apoptosis of Activated HSC-T6 Cells. Molecules 2016;21:E1599. [PMID: 27886086 DOI: 10.3390/molecules21111599] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
202 Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol. 2006;41:209-224. [PMID: 16492723 DOI: 10.1093/alcalc/agl011] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
203 Weiskirchen R, Mahli A, Weiskirchen S, Hellerbrand C. The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Front Physiol 2015;6:140. [PMID: 25999863 DOI: 10.3389/fphys.2015.00140] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
204 Khan F, Peltekian KM, Peterson TC. Effect of interferon-alpha, ribavirin, pentoxifylline, and interleukin-18 antibody on hepatitis C sera-stimulated hepatic stellate cell proliferation. J Interferon Cytokine Res 2008;28:643-51. [PMID: 18844579 DOI: 10.1089/jir.2007.0123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
205 Li X, Zhang H, Pan L, Zou H, Miao X, Cheng J, Wu Y. Puerarin alleviates liver fibrosis via inhibition of the ERK1/2 signaling pathway in thioacetamide-induced hepatic fibrosis in rats. Exp Ther Med 2019;18:133-8. [PMID: 31258646 DOI: 10.3892/etm.2019.7534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
206 Qiang H, Lin Y, Zhang X, Zeng X, Shi J, Chen YX, Yang MF, Han ZG, Xie WF. Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver Int. 2006;26:1126-1137. [PMID: 17032414 DOI: 10.1111/j.1478-3231.2006.01353.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
207 Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology. 2003;37:1043-1055. [PMID: 12717385 DOI: 10.1053/jhep.2003.50182] [Cited by in Crossref: 460] [Cited by in F6Publishing: 435] [Article Influence: 25.6] [Reference Citation Analysis]
208 Meurer SK, Tihaa L, Lahme B, Gressner AM, Weiskirchen R. Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling. J Biol Chem. 2005;280:3078-3087. [PMID: 15537649 DOI: 10.1074/jbc.m405411200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
209 Kuzu N, Metin K, Dagli AF, Akdemir F, Orhan C, Yalniz M, Ozercan IH, Sahin K, Bahcecioglu IH. Protective role of genistein in acute liver damage induced by carbon tetrachloride. Mediators Inflamm 2007;2007:36381. [PMID: 17597837 DOI: 10.1155/2007/36381] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
210 Chen YX, Weng ZH, Zhang SL. Notch3 regulates the activation of hepatic stellate cells. World J Gastroenterol 2012; 18(12): 1397-1403 [PMID: 22493555 DOI: 10.3748/wjg.v18.i12.1397] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
211 Tashiro K, Satoh A, Utsumi T, Chung C, Iwakiri Y. Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice. Am J Pathol 2013;182:786-95. [PMID: 23313137 DOI: 10.1016/j.ajpath.2012.11.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
212 Wang J, Ding Y, Zhou W. Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways. Int J Pharm 2020;574:118940. [PMID: 31830578 DOI: 10.1016/j.ijpharm.2019.118940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
213 Maubach G, Lim MC, Kumar S, Zhuo L. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment. Biochim Biophys Acta 2007;1773:219-31. [PMID: 17178165 DOI: 10.1016/j.bbamcr.2006.11.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
214 Andrewartha N, Yeoh G. Human Amnion Epithelial Cell Therapy for Chronic Liver Disease. Stem Cells Int 2019;2019:8106482. [PMID: 31485235 DOI: 10.1155/2019/8106482] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
215 Lu W, Li X, Liu N, Zhang Y, Li Y, Pan Y, Yang J, Liu Z, Kong J. Vitamin D alleviates liver fibrosis by inhibiting histidine-rich calcium binding protein (HRC). Chem Biol Interact 2021;334:109355. [PMID: 33309619 DOI: 10.1016/j.cbi.2020.109355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
216 Bárcena C, Stefanovic M, Tutusaus A, Joannas L, Menéndez A, García-Ruiz C, Sancho-Bru P, Marí M, Caballeria J, Rothlin CV. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J Hepatol. 2015;63:670-678. [PMID: 25908269 DOI: 10.1016/j.jhep.2015.04.013] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 11.2] [Reference Citation Analysis]
217 Zhang LJ, Zheng WD, Shi MN, Wang XZ. Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver. World J Gastroenterol 2006; 12(12): 1918-1923 [PMID: 16609999 DOI: 10.3748/wjg.v12.i12.1918] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
218 Bestion E, Jilkova ZM, Mège JL, Novello M, Kurma K, Pour STA, Lalmanach G, Vanderlynden L, Fizanne L, Bassissi F, Rachid M, Tracz J, Boursier J, Courcambeck J, Serdjebi C, Ansaldi C, Decaens T, Halfon P, Brun S. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Ther Adv Chronic Dis 2020;11:2040622320942042. [PMID: 32728410 DOI: 10.1177/2040622320942042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
219 Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta. 2006;364:33-60. [PMID: 16139830 DOI: 10.1016/j.cca.2005.06.014] [Cited by in Crossref: 223] [Cited by in F6Publishing: 232] [Article Influence: 13.9] [Reference Citation Analysis]
220 Zhao L, Gandhi CR, Gao ZH. Involvement of cytosolic phospholipase A2 alpha signalling pathway in spontaneous and transforming growth factor-beta-induced activation of rat hepatic stellate cells. Liver Int. 2011;31:1565-1573. [PMID: 22093332 DOI: 10.1111/j.1478-3231.2011.02632.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
221 Lee JH, Jang EJ, Seo HL, Ku SK, Lee JR, Shin SS, Park SD, Kim SC, Kim YW. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway. Chem Biol Interact. 2014;224:58-67. [PMID: 25451574 DOI: 10.1016/j.cbi.2014.10.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
222 Shi MN, Huang YH, Zheng WD, Zhang LJ, Chen ZX, Wang XZ. Relationship between transforming growth factor β1 and anti-fibrotic effect of interleukin-10. World J Gastroenterol 2006; 12(15): 2357-2362 [PMID: 16688825 DOI: 10.3748/wjg.v12.i15.2357] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
223 Subramaniam N, Sherman MH, Rao R, Wilson C, Coulter S, Atkins AR, Evans RM, Liddle C, Downes M. Metformin-mediated Bambi expression in hepatic stellate cells induces prosurvival Wnt/β-catenin signaling. Cancer Prev Res (Phila). 2012;5:553-561. [PMID: 22406377 DOI: 10.1158/1940-6207.capr-12-0053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
224 Xiong LJ, Zhu JF, Luo DD, Zen LL, Cai SQ. Effects of pentoxifylline on the hepatic content of TGF-β1 and collagen in Schistosomiasis japonica mice with liver fibrosis. World J Gastroenterol 2003; 9(1): 152-154 [PMID: 12508372 DOI: 10.3748/wjg.v9.i1.152] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
225 Park YJ, Kim DM, Jeong MH, Yu JS, So HM, Bang IJ, Kim HR, Kwon SH, Kim KH, Chung KH. (-)-Catechin-7-O-β-d-Apiofuranoside Inhibits Hepatic Stellate Cell Activation by Suppressing the STAT3 Signaling Pathway. Cells 2019;9:E30. [PMID: 31861943 DOI: 10.3390/cells9010030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
226 Van de Casteele M, Roskams T, Van der Elst I, van Pelt JF, Fevery J, Nevens F. Halofuginone can worsen liver fibrosis in bile duct obstructed rats. Liver Int 2004;24:502-9. [DOI: 10.1111/j.1478-3231.2004.0950.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
227 Freise C, Heldwein S, Erben U, Hoyer J, Köhler R, Jöhrens K, Patsenker E, Ruehl M, Seehofer D, Stickel F, Somasundaram R. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells. Liver Int 2015;35:1244-52. [PMID: 25212242 DOI: 10.1111/liv.12681] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
228 Kim J, Jung Y. Potential role of thymosin Beta 4 in liver fibrosis. Int J Mol Sci 2015;16:10624-35. [PMID: 26006229 DOI: 10.3390/ijms160510624] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
229 Izawa T, Horiuchi T, Atarashi M, Kuwamura M, Yamate J. Anti-fibrotic Role of miR-214 in Thioacetamide-induced Liver Cirrhosis in Rats. Toxicol Pathol. 2015;43:844-851. [PMID: 25755099 DOI: 10.1177/0192623315573587] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
230 Yoshida K, Matsuzaki K. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Front Physiol. 2012;3:53. [PMID: 22457652 DOI: 10.3389/fphys.2012.00053] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 8.4] [Reference Citation Analysis]
231 Lubel JS, Herath CB, Burrell LM, Angus PW. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol. 2008;23:1327-1338. [PMID: 18557800 DOI: 10.1111/j.1440-1746.2008.05461.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 6.2] [Reference Citation Analysis]
232 Osawa Y, Seki E, Adachi M, Taura K, Kodama Y, Siegmund SV, Schwabe RF, Brenner DA. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation. Liver Int. 2006;26:1138-1147. [PMID: 17032415 DOI: 10.1111/j.1478-3231.2006.01346.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
233 Nunez Lopez O, Bohanon FJ, Wang X, Ye N, Corsello T, Rojas-Khalil Y, Chen H, Chen H, Zhou J, Radhakrishnan RS. STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis. RSC Adv 2016;6:100652-63. [PMID: 28546859 DOI: 10.1039/C6RA17459K] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
234 Ding H, Shi J, Wang Y, Guo J, Zhao J, Dong L. Neferine inhibits cultured hepatic stellate cell activation and facilitates apoptosis: A possible molecular mechanism. Eur J Pharmacol 2011;650:163-9. [PMID: 20969858 DOI: 10.1016/j.ejphar.2010.10.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
235 Kanemoto H, Ohno K, Sakai M, Nakashima K, Takahashi M, Fujino Y, Tsujimoto H. Expression of fibrosis-related genes in canine chronic hepatitis. Vet Pathol 2011;48:839-45. [PMID: 21118800 DOI: 10.1177/0300985810388523] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
236 Dasarathy S. Inflammation and liver. JPEN J Parenter Enteral Nutr. 2008;32:660-666. [PMID: 18974249 DOI: 10.1177/0148607108324584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
237 Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, Yokoyama T, Takii Y, Mori T, Yatsuhashi H, Eguchi K, Ishibashi H. Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells. Life Sci 2006;78:2510-5. [PMID: 16303143 DOI: 10.1016/j.lfs.2005.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
238 Falasca K, Ucciferri C, Mancino P, Vitacolonna E, De Tullio D, Pizzigallo E, Conti P, Vecchiet J. Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection. J Med Virol 2008;80:1900-6. [PMID: 18814247 DOI: 10.1002/jmv.21292] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
239 Dornas W, Glaise D, Bodin A, Sharanek A, Burban A, Le Guillou D, Robert S, Dutertre S, Aninat C, Corlu A, Lagente V. Endotoxin regulates matrix genes increasing reactive oxygen species generation by intercellular communication between palmitate-treated hepatocyte and stellate cell. J Cell Physiol 2018;234:122-33. [PMID: 30191979 DOI: 10.1002/jcp.27175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
240 Kitano M, Bloomston PM. Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis. J Clin Med. 2016;5. [PMID: 26999230 DOI: 10.3390/jcm5030038] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
241 Kim IH, Kim DG, Hao P, Wang Y, Kim SH, Kim SW, Lee SO, Lee ST. Anti-fibrotic effects of L-2-oxothiazolidine-4-carboxylic acid via modulation of nuclear factor erythroid 2-related factor 2 in rats. BMB Rep 2012;45:348-53. [PMID: 22732220 DOI: 10.5483/bmbrep.2012.45.6.276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
242 Huang L, Xie J, Bi Q, Li Z, Liu S, Shen Q, Li C. Highly Selective Targeting of Hepatic Stellate Cells for Liver Fibrosis Treatment Using a d-Enantiomeric Peptide Ligand of Fn14 Identified by Mirror-Image mRNA Display. Mol Pharm 2017;14:1742-53. [PMID: 28358987 DOI: 10.1021/acs.molpharmaceut.6b01174] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
243 Kim KM, Yoon J, Gwak G, Kim W, Hee Lee S, June Jang J, Lee H. Bile acid-mediated induction of cyclooxygenase-2 and Mcl-1 in hepatic stellate cells. Biochemical and Biophysical Research Communications 2006;342:1108-13. [DOI: 10.1016/j.bbrc.2006.02.072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
244 Zhao WX, Zhao J, Liang CL, Zhao B, Pang RQ, Pan XH. Effect of caffeic acid phenethyl ester on proliferation and apoptosis of hepatic stellate cells in vitroWorld J Gastroenterol 2003; 9(6): 1278-1281 [PMID: 12800240 DOI: 10.3748/wjg.v9.i6.1278] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
245 Wang L, Wang BE, Wang J, Xiao PG, Tan XH. Herbal compound 861 regulates mRNA expression of collagen synthesis- and degradation-related genes in human hepatic stellate cells. World J Gastroenterol 2008; 14(11): 1790-1794 [PMID: 18350612 DOI: 10.3748/wjg.14.1790] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
246 Bataller R. Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 2003;37:493-503. [DOI: 10.1053/jhep.2003.50127] [Cited by in Crossref: 235] [Cited by in F6Publishing: 217] [Article Influence: 13.1] [Reference Citation Analysis]
247 Migita K, Maeda Y, Abiru S, Komori A, Yokoyama T, Takii Y, Nakamura M, Yatsuhashi H, Eguchi K, Ishibashi H. Peroxynitrite-mediated matrix metalloproteinase-2 activation in human hepatic stellate cells. FEBS Letters 2005;579:3119-25. [DOI: 10.1016/j.febslet.2005.04.071] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
248 Saito S, Hata K, Iwaisako K, Yanagida A, Takeiri M, Tanaka H, Kageyama S, Hirao H, Ikeda K, Asagiri M, Uemoto S. Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis. Hepatol Res 2014;44:460-73. [PMID: 23607402 DOI: 10.1111/hepr.12140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
249 Shen A, Zhang B, Ping J, Xie W, Donfack P, Baek S, Zhou X, Wang H, Materny A, Hu J. In vivo study on the protection of indole-3-carbinol (I3C) against the mouse acute alcoholic liver injury by micro-Raman spectroscopy: Protection of I3C against mouse liver injury by MRS. J Raman Spectrosc 2009;40:550-5. [DOI: 10.1002/jrs.2163] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
250 Brunati AM, Pagano MA, Bindoli A, Rigobello MP. Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes. Free Radic Res 2010;44:363-78. [PMID: 20166884 DOI: 10.3109/10715760903555836] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
251 Chen Y, Zheng S, Qi D, Zheng S, Guo J, Zhang S, Weng Z. Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One. 2012;7:e46512. [PMID: 23056328 DOI: 10.1371/journal.pone.0046512] [Cited by in Crossref: 78] [Cited by in F6Publishing: 93] [Article Influence: 8.7] [Reference Citation Analysis]
252 Delgado I, Carrasco M, Cano E, Carmona R, García-Carbonero R, Marín-Gómez LM, Soria B, Martín F, Cano DA, Muñoz-Chápuli R, Rojas A. GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice. Hepatology 2014;59:2358-70. [PMID: 24415412 DOI: 10.1002/hep.27005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
253 Osawa Y, Oboki K, Imamura J, Kojika E, Hayashi Y, Hishima T, Saibara T, Shibasaki F, Kohara M, Kimura K. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice. EBioMedicine. 2015;2:1751-1758. [PMID: 26870800 DOI: 10.1016/j.ebiom.2015.10.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
254 Valentino G, Zivko C, Weber F, Brülisauer L, Luciani P. Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics 2019;11:E676. [PMID: 31842373 DOI: 10.3390/pharmaceutics11120676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
255 Neuman MG, Monteiro M, Rehm J. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Subst Use Misuse 2006;41:1395-463. [PMID: 17002989 DOI: 10.1080/10826080600846235] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
256 Iredale JP. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ. 2003;327:143-147. [PMID: 12869458 DOI: 10.1136/bmj.327.7407.143] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 6.9] [Reference Citation Analysis]
257 Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011;412:74-79. [PMID: 21798245 DOI: 10.1016/j.bbrc.2011.07.041] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 11.9] [Reference Citation Analysis]
258 Asada K, Kaji K, Sato S, Seki K, Shimozato N, Kawaratani H, Takaya H, Sawada Y, Nakanishi K, Furukawa M, Kitade M, Moriya K, Namisaki T, Noguchi R, Akahane T, Yoshiji H. Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2'-deoxycytidine in Hepatic Stellate Cells. Biology (Basel) 2020;9:E117. [PMID: 32503264 DOI: 10.3390/biology9060117] [Reference Citation Analysis]
259 Apte M. Oxidative stress: does it 'initiate' hepatic stellate cell activation or only 'perpetuate' the process? J Gastroenterol Hepatol. 2002;17:1045-1048. [PMID: 12201862 DOI: 10.1046/j.1440-1746.2002.02845.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
260 Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7312-7324 [PMID: 24966602 DOI: 10.3748/wjg.v20.i23.7312] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 178] [Article Influence: 28.9] [Reference Citation Analysis]
261 Mansy SS, Nosseir MM, Othman MM, Zoheiry MA, Guda MF, Yehia HA, Hassanein MH. Spotlight on the three main hepatic fibrogenic cells in HCV-infected patients: Multiple immunofluorescence and ultrastructure study. Ultrastructural Pathology 2016;40:276-87. [DOI: 10.1080/01913123.2016.1194507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
262 Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med. 1999;40:1407-1413. [PMID: 10492357 DOI: 10.1002/jcp.21481] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
263 Vicentino ARR, Carneiro VC, Allonso D, Guilherme RF, Benjamim CF, Dos Santos HAM, Xavier F, Pyrrho ADS, Gomes JAS, Fonseca MC, de Oliveira RC, Pereira TA, Ladislau L, Lambertucci JR, Fantappié MR. Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis. Front Immunol 2018;9:1979. [PMID: 30258438 DOI: 10.3389/fimmu.2018.01979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
264 Wu YM, Xu N, Hu JY, Xu XF, Wu WX, Gao SX, Zhu WJ, Wu WL, Shen XZ, Wang JY, Wu SD. A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica. Parasitol Int 2013;62:283-8. [PMID: 23466574 DOI: 10.1016/j.parint.2013.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
265 Chor SY, Hui AY, To KF, Chan KK, Go YY, Chan HL, Leung WK, Sung JJ. Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. J Ethnopharmacol. 2005;100:180-186. [PMID: 15950418 DOI: 10.1016/j.jep.2005.02.036] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
266 Abu-elsaad NM, Serrya MS, El-karef AM, Ibrahim TM. The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice. Pharmacological Reports 2016;68:275-82. [DOI: 10.1016/j.pharep.2015.08.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
267 Li J, Li X, Xu W, Wang S, Hu Z, Zhang Q, Deng X, Wang J, Zhang J, Guo C. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways. Liver Int 2015;35:1222-33. [DOI: 10.1111/liv.12638] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
268 Kawano Y, Ohta M, Iwashita Y, Komori Y, Inomata M, Kitano S. Effects of the dihydrolipoyl histidinate zinc complex against carbon tetrachloride-induced hepatic fibrosis in rats. Surg Today 2014;44:1744-50. [PMID: 24121950 DOI: 10.1007/s00595-013-0749-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
269 Peng Y, Tao Y, Wang Q, Shen L, Yang T, Liu Z, Liu C. Ergosterol Is the Active Compound of Cultured Mycelium Cordyceps sinensis on Antiliver Fibrosis. Evid Based Complement Alternat Med 2014;2014:537234. [PMID: 25386220 DOI: 10.1155/2014/537234] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
270 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1111/j.1582-4934.2006.tb00292.x] [Cited by in Crossref: 512] [Cited by in F6Publishing: 526] [Article Influence: 34.1] [Reference Citation Analysis]
271 Ye L, Yu Y, Zhao Y. Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. J Gastroenterol Hepatol 2020;35:482-91. [PMID: 31617598 DOI: 10.1111/jgh.14875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
272 Li WQ, Chen C, Xu MD, Guo J, Li YM, Xia QM, Liu HM, He J, Yu HY, Zhu L. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J. 2011;278:1522-1532. [PMID: 21366874 DOI: 10.1111/j.1742-4658.2011.08075.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
273 Amer MG, Mazen NF, Mohamed AM. Caffeine intake decreases oxidative stress and inflammatory biomarkers in experimental liver diseases induced by thioacetamide: Biochemical and histological study. Int J Immunopathol Pharmacol 2017;30:13-24. [PMID: 28281876 DOI: 10.1177/0394632017694898] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
274 Kisseleva T, Brenner DA. Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol. 2006;21 Suppl 3:S84-S87. [PMID: 16958681 DOI: 10.1111/j.1440-1746.2006.04584.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 170] [Article Influence: 12.3] [Reference Citation Analysis]
275 Paik YH, Kim J, Aoyama T, De Minicis S, Bataller R, Brenner DA. Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal 2014;20:2854-72. [PMID: 24040957 DOI: 10.1089/ars.2013.5619] [Cited by in Crossref: 133] [Cited by in F6Publishing: 118] [Article Influence: 19.0] [Reference Citation Analysis]
276 Zhou B, Yuan W, Li X. LncRNA Gm5091 alleviates alcoholic hepatic fibrosis by sponging miR-27b/23b/24 in mice: Gm5091 sponges miR-27b/23b/24 to inhibit live fibrosis. Cell Biol Int 2018;42:1330-9. [DOI: 10.1002/cbin.11021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
277 Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, Chung RT. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int. 2009;29:748-753. [PMID: 19220742 DOI: 10.1111/j.1478-3231.2009.01973.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
278 Pinzani M. Therapies for hepatic fibrosis: real hope or just academic exercise? Digestive and Liver Disease 2004;36:714-6. [DOI: 10.1016/j.dld.2004.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
279 Yao L, Yao ZM, Weng H, Zhao GP, Zhou YJ, Yu T. Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cells. World J Gastroenterol 2004; 10(13): 1911-1913 [PMID: 15222035 DOI: 10.3748/wjg.v10.i13.1911] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
280 Kim SY, Cho BH, Kim UH. CD38-mediated Ca2+ signaling contributes to angiotensin II-induced activation of hepatic stellate cells: attenuation of hepatic fibrosis by CD38 ablation. J Biol Chem. 2010;285:576-582. [PMID: 19910464 DOI: 10.1074/jbc.m109.076216] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
281 Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA. 2005;102:3389-3394. [PMID: 15728360 DOI: 10.1073/pnas.0409722102] [Cited by in Crossref: 243] [Cited by in F6Publishing: 226] [Article Influence: 15.2] [Reference Citation Analysis]
282 Yang FR, Fang BW, Lou JS. Effects of Haobie Yangyin Ruanjian Decoction on hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol 2010; 16(12): 1458-1464 [PMID: 20333785 DOI: 10.3748/wjg.v16.i12.1458] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
283 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/JCI200524282.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
284 Mühlbauer M, Weiss TS, Thasler WE, Gelbmann CM, Schnabl B, Schölmerich J, Hellerbrand C. LPS-mediated NFκB activation varies between activated human hepatic stellate cells from different donors. Biochemical and Biophysical Research Communications 2004;325:191-7. [DOI: 10.1016/j.bbrc.2004.10.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
285 Cho MK, Lee GH, Park EY, Kim SG. Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis. Tissue Cell 2004;36:293-305. [PMID: 15385147 DOI: 10.1016/j.tice.2004.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
286 Wang Y, Jiang J. Influence of Tissue Microstructure on Shear Wave Speed Measurements in Plane Shear Wave Elastography: A Computational Study in Lossless Fibrotic Liver Media. Ultrason Imaging 2018;40:49-63. [PMID: 28720056 DOI: 10.1177/0161734617719055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
287 Zeng Z, Wu Y, Cao Y, Yuan Z, Zhang Y, Zhang DY, Hasegawa D, Friedman SL, Guo J. Slit2-Robo2 signaling modulates the fibrogenic activity and migration of hepatic stellate cells. Life Sci 2018;203:39-47. [PMID: 29660433 DOI: 10.1016/j.lfs.2018.04.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
288 Luo X, Zhang D, Xie J, Su Q, He X, Bai R, Gao G, Pan W. MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7. Mol Ther Methods Clin Dev 2018;11:73-82. [PMID: 30406154 DOI: 10.1016/j.omtm.2018.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
289 Paiva LA, Coelho KA, Luna-Gomes T, El-Cheikh MC, Borojevic R, Perez SA, Bozza PT, Bandeira-Melo C. Schistosome infection-derived Hepatic Stellate Cells are cellular source of prostaglandin D₂: role in TGF-β-stimulated VEGF production. Prostaglandins Leukot Essent Fatty Acids 2015;95:57-62. [PMID: 25687497 DOI: 10.1016/j.plefa.2015.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
290 Semiane N, Foufelle F, Ferré P, Hainault I, Ameddah S, Mallek A, Khalkhal A, Dahmani Y. High carbohydrate diet induces nonalcoholic steato-hepatitis (NASH) in a desert gerbil. Comptes Rendus Biologies 2017;340:25-36. [DOI: 10.1016/j.crvi.2016.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
291 Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol. 2007;22 Suppl 1:S73-S78. [PMID: 17567473 DOI: 10.1111/j.1440-1746.2006.04658.x] [Cited by in Crossref: 188] [Cited by in F6Publishing: 183] [Article Influence: 13.4] [Reference Citation Analysis]
292 Lim MP, Devi LA, Rozenfeld R. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis 2011;2:e170. [PMID: 21654828 DOI: 10.1038/cddis.2011.52] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 6.5] [Reference Citation Analysis]
293 Mas N, Tasci I, Comert B, Ocal R, Mas MR. Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis. World J Gastroenterol 2008; 14(7): 1108-1111 [PMID: 18286695 DOI: 10.3748/wjg.14.1108] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
294 Lombardi R, Buzzetti E, Roccarina D, Tsochatzis EA. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol 2015; 21(39): 11044-11052 [PMID: 26494961 DOI: 10.3748/wjg.v21.i39.11044] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
295 Anuja G, Shine V, Latha P, Suja S. Protective effect of ethyl acetate fraction of Drynaria quercifolia against CCl 4 induced rat liver fibrosis via Nrf2/ARE and NFκB signalling pathway. Journal of Ethnopharmacology 2018;216:79-88. [DOI: 10.1016/j.jep.2017.11.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
296 聂青和. 肝纤维化的逆转策略及研究现状. 世界华人消化杂志 2005; 13(10): 1165-1174 [DOI: 10.11569/wcjd.v13.i10.1165] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
297 Duan YN, Qian HY, Qin YW, Zhu DD, He XX, Zhou Q, Yang YN, Bao J, Feng JR, Sun W, Chen JL. Dynamics of Sept4 expression in fibrotic livers of mice infected with Schistosoma japonicum. Parasitology 2011;138:1003-10. [DOI: 10.1017/s0031182011000667] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
298 Koyama Y, Taura K, Hatano E, Tanabe K, Yamamoto G, Nakamura K, Yamanaka K, Kitamura K, Narita M, Nagata H. Effects of oral intake of hydrogen water on liver fibrogenesis in mice. Hepatol Res. 2014;44:663-677. [PMID: 23682614 DOI: 10.1111/hepr.12165] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
299 Wu X, Wang Y, Wang S, Xu R, Lv X. Purinergic P2X7 receptor mediates acetaldehyde-induced hepatic stellate cells activation via PKC-dependent GSK3β pathway. Int Immunopharmacol 2017;43:164-71. [PMID: 28061416 DOI: 10.1016/j.intimp.2016.12.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
300 Siegmund SV, Qian T, de Minicis S, Harvey-White J, Kunos G, Vinod KY, Hungund B, Schwabe RF. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J. 2007;21:2798-2806. [PMID: 17440119 DOI: 10.1096/fj.06-7717com] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 6.9] [Reference Citation Analysis]
301 Siegmund SV, Brenner DA. Molecular pathogenesis of alcohol-induced hepatic fibrosis. Alcohol Clin Exp Res. 2005;29:102S-109S. [PMID: 16344593 DOI: 10.1097/01.alc.0000189275.97419.58] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
302 Povero D, Feldstein AE. Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. Diabetes Metab J 2016;40:1-11. [PMID: 26912150 DOI: 10.4093/dmj.2016.40.1.1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
303 Maubach G, Lim MCC, Zhang CY, Zhuo L. GFAP promoter directs lacZ expression specifically in a rat hepatic stellate cell line. World J Gastroenterol 2006; 12(5): 723-730 [PMID: 16521185 DOI: 10.3748/wjg.v12.i5.723] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
304 Li Y, Kim BG, Qian S, Letterio JJ, Fung JJ, Lu L, Lin F. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex. J Immunol 2015;195:2648-56. [PMID: 26246140 DOI: 10.4049/jimmunol.1500139] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
305 Loguercio C, Federico A, Trappoliere M, Tuccillo C, de Sio I, Di Leva A, Niosi M, D’Auria MV, Capasso R, Del Vecchio Blanco C. The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci. 2007;52:2387-2395. [PMID: 17410454 DOI: 10.1007/s10620-006-9703-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
306 Amin A, Mahmoud-Ghoneim D. Zizyphus spina-christi protects against carbon tetrachloride-induced liver fibrosis in rats. Food Chem Toxicol 2009;47:2111-9. [PMID: 19500642 DOI: 10.1016/j.fct.2009.05.038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
307 Deng X, Liang J, Lin ZX, Wu FS, Zhang YP, Zhang ZW. Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis. World J Gastroenterol 2010; 16(15): 1916-1923 [PMID: 20397272 DOI: 10.3748/wjg.v16.i15.1916] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
308 Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology. 2005;41:1085-1095. [PMID: 15841466 DOI: 10.1002/hep.20667] [Cited by in Crossref: 135] [Cited by in F6Publishing: 129] [Article Influence: 8.4] [Reference Citation Analysis]
309 Park YJ, An HT, Park JS, Park O, Duh AJ, Kim K, Chung KH, Lee KC, Oh Y, Lee S. Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells. Sci Rep 2020;10:14756. [PMID: 32901093 DOI: 10.1038/s41598-020-71688-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Liang FF, Liu CP, Li LX, Xue MM, Xie F, Guo Y, Bai L. Activated effects of parathyroid hormone-related protein on human hepatic stellate cells. PLoS One 2013;8:e76517. [PMID: 24116114 DOI: 10.1371/journal.pone.0076517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
311 Palladini G, Ferrigno A, Richelmi P, Perlini S, Vairetti M. Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review. World J Gastroenterol 2015; 21(42): 12114-12124 [PMID: 26576096 DOI: 10.3748/wjg.v21.i42.12114] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
312 Liu Q, Zhang Y, Yang S, Wu Y, Wang J, Yu W, Liu Y. PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of miR-34a and miR-29c in hepatic stellate cells. Biosci Rep 2017;37:BSR20170926. [PMID: 29162670 DOI: 10.1042/BSR20170926] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
313 Yoshida K, Matsuzaki K. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Front Physiol. 2012;3:53. [PMID: 22457652 DOI: 10.3389/fphys]] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76-99. [PMID: 16563223 DOI: 10.1634/stemcells.2007-0252"> [DOI: 10.1111/j.1582-4934.2006.tb00292.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Kwak KG, Wang JH, Shin JW, Lee DS, Son CG. A traditional formula, Chunggan extract, attenuates thioacetamide-induced hepatofibrosis via GSH system in rats. Hum Exp Toxicol. 2011;30:1322-1332. [PMID: 21071552 DOI: 10.1177/0960327110389502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
316 Grizzi F, Franceschini B, Gagliano N, Moscheni C, Annoni G, Vergani C, Hermonat PL, Chiriva-Internati M, Dioguardi N. Mast cell density, hepatic stellate cell activation and TGF-beta1 transcripts in the aging Sprague-Dawley rat during early acute liver injury. Toxicol Pathol 2003;31:173-8. [PMID: 12696576 DOI: 10.1080/01926230390183643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
317 Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007;315:1853-6. [PMID: 17395831 DOI: 10.1126/science.1137603] [Cited by in Crossref: 121] [Cited by in F6Publishing: 124] [Article Influence: 8.6] [Reference Citation Analysis]
318 Park S, Choi S, Lee MG, Lim C, Oh J. Retinol binding protein-albumin domain III fusion protein deactivates hepatic stellate cells. Mol Cells 2012;34:517-22. [PMID: 23161170 DOI: 10.1007/s10059-012-0183-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
319 Hemeda AA, Ahmad Mohamed A, Aziz RK, Abdel-Hakeem MS, Ali-Tammam M. Impact of IL10, MTP, SOD2, and APOE Gene Polymorphisms on the Severity of Liver Fibrosis Induced by HCV Genotype 4. Viruses 2021;13:714. [PMID: 33924242 DOI: 10.3390/v13040714] [Reference Citation Analysis]
320 Lin HJ, Chen JY, Lin CF, Kao ST, Cheng JC, Chen HL, Chen CM. Hepatoprotective effects of Yi Guan Jian, an herbal medicine, in rats with dimethylnitrosamine-induced liver fibrosis. J Ethnopharmacol 2011;134:953-60. [PMID: 21333722 DOI: 10.1016/j.jep.2011.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
321 Bataller R, Ginès P. [New therapeutic strategies in liver fibrosis: pathogenic basis]. Med Clin (Barc) 2002;118:339-46. [PMID: 11900704 DOI: 10.1016/s0025-7753(02)72380-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
322 Rombouts K, Kisanga E, Hellemans K, Wielant A, Schuppan D, Geerts A. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol. 2003;38:564-572. [PMID: 12713866 DOI: 10.1016/s0168-8278(03)00051-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
323 Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest. 2003;112:1383-1394. [PMID: 14597764 DOI: 10.1172/jci200318212] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
324 Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, Solé M, Colmenero J, Nicolás JM, Jiménez W, Weich N. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology. 2003;125:117-125. [PMID: 12851877 DOI: 10.1016/s0016-5085(03)00695-4] [Cited by in Crossref: 235] [Cited by in F6Publishing: 106] [Article Influence: 13.1] [Reference Citation Analysis]
325 Zhong L, Sun YL, Shi WL, Ma X, Chen Z, Wang JB, Li RS, Song XA, Liu HH, Zhao YL, Xiao XH. Protective effect of fu-qi granule on carbon tetrachloride-induced liver fibrosis in rats. World J Pharmacol 2015; 4(2): 227-235 [DOI: 10.5497/wjp.v4.i2.227] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
326 Kang R, Tian W, Cao W, Sun Y, Zhang HN, Feng YD, Li C, Li ZZ, Li XQ. Ligustroflavone ameliorates CCl4-induced liver fibrosis through down-regulating the TGF-β/Smad signaling pathway. Chin J Nat Med 2021;19:170-80. [PMID: 33781450 DOI: 10.1016/S1875-5364(21)60018-3] [Reference Citation Analysis]
327 Deng Y, Ma H, Tsuneyama K, Yang W, Wang Y, Lu F, Liu C, Liu P, He X, Diehl AM, Gershwin ME, Lian Z. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. Journal of Autoimmunity 2013;46:25-34. [DOI: 10.1016/j.jaut.2013.07.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
328 Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr. 2004;144:123-125. [PMID: 14722530 DOI: 10.1016/j.jpeds.2003.09.042] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
329 Arteaga M, Shang N, Ding X, Yong S, Cotler SJ, Denning MF, Shimamura T, Breslin P, Lüscher B, Qiu W. Inhibition of SIRT2 suppresses hepatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2016;310:G1155-68. [PMID: 27125275 DOI: 10.1152/ajpgi.00271.2015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
330 Bataller R, Sancho-Bru P, Ginès P, Brenner DA. Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid Redox Signal. 2005;7:1346-1355. [PMID: 16115040 DOI: 10.1089/ars.2005.7.1346] [Cited by in Crossref: 111] [Cited by in F6Publishing: 110] [Article Influence: 7.4] [Reference Citation Analysis]
331 Benlloch S, Beltrán B, Moreno R, Berenguer M. [Fibrogenesis and liver transplantation]. Gastroenterol Hepatol 2003;26:381-95. [PMID: 12809575 DOI: 10.1016/s0210-5705(03)70375-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
332 Center SA. Metabolic, antioxidant, nutraceutical, probiotic, and herbal therapies relating to the management of hepatobiliary disorders. Vet Clin North Am Small Anim Pract 2004;34:67-172, vi. [PMID: 15032126 DOI: 10.1016/j.cvsm.2003.09.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
333 Shi J, Hao JH, Ren WH, Zhu JR. Effects of heparin on liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol 2003; 9(7): 1611-1614 [PMID: 12854176 DOI: 10.3748/wjg.v9.i7.1611] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
334 Ye Z, Houssein HS, Mahato RI. Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides 2007;17:349-404. [PMID: 18154454 DOI: 10.1089/oli.2007.0097] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
335 Gonzalo T, Talman EG, van de Ven A, Temming K, Greupink R, Beljaars L, Reker-Smit C, Meijer DK, Molema G, Poelstra K, Kok RJ. Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology. J Control Release 2006;111:193-203. [PMID: 16466667 DOI: 10.1016/j.jconrel.2005.12.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
336 Lee IH, Im E, Lee H, Sim DY, Lee JH, Jung JH, Park JE, Shim BS, Kim S. Apoptotic and antihepatofibrotic effect of honokiol via activation of GSK3β and suppression of Wnt/β‐catenin pathway in hepatic stellate cells. Phytotherapy Research 2021;35:452-62. [DOI: 10.1002/ptr.6824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
337 Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology. 2003;38:879-889. [PMID: 14512875 DOI: 10.1002/hep.1840380414] [Cited by in Crossref: 122] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
338 Wang L, Wang J, Wang BE, Xiao PG, Qiao YJ, Tan XH. Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation. World J Gastroenterol 2004; 10(19): 2831-2835 [PMID: 15334680 DOI: 10.3748/wjg.v10.i19.2831] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
339 Kang KH, Qian ZJ, Ryu B, Karadeniz F, Kim D, Kim SK. Hepatic Fibrosis Inhibitory Effect of Peptides Isolated from Navicula incerta on TGF-β1 Induced Activation of LX-2 Human Hepatic Stellate Cells. Prev Nutr Food Sci 2013;18:124-32. [PMID: 24471121 DOI: 10.3746/pnf.2013.18.2.124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
340 Greupink R, Reker-Smit C, Proost JH, van Loenen Weemaes AM, de Hooge M, Poelstra K, Beljaars L. Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated rats. Biochem Pharmacol 2007;73:1455-62. [PMID: 17239825 DOI: 10.1016/j.bcp.2006.12.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]